Pharmaceutical company ScripsAmerica, Inc. has announced that it received and processed $116,987 in November as a result of its recent pharmaceutical distribution joint venture.
For October and November, revenues of $246,781 were generated through the joint venture as a result of ScripsAmerica providing independent pharmacies with wholesale prescription drugs. The combined October and November sales keep ScripsAmerica on a run rate of more than $1.4 million just for this joint venture.
"November proved to be a very strong month in sales for our joint venture, even with the Thanksgiving holiday, therefore keeping pace with previous months," said ScripsAmerica CEO Bob Schneiderman. "Our run rate continues to be in the $1.5 million range and we expect to increase this rate as our partner continues its growth in the industry. We fully expect that wholesale pharmaceutical distribution to independent pharmacies will remain an area of steady growth for ScripsAmerica and our shareholder value throughout 2014."
A supplier of prescription, OTC, and nutraceutical drugs, ScripsAmerica delivers pharmaceutical products to a broad range of end users across the healthcare industry, including retail pharmacies, hospitals, long-term care facilities, and government and home care agencies.
For more information, visit ScripsAmerica.com
QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net